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Abstract: 
Background: Anti-TNF therapy has revolutionised the management of rheumatoid arthritis (RA) with 
rapid and sustained improvements in pain, function and quality of life. However, we do not know 
how this impacts upon habitual daily physical activity and whether treated patients attain activity 
levels seen in healthy controls. This study aimed to compare the physical activity levels of patients 
whose RA was well controlled on long-term anti-TNF therapy to RA patients with active arthritis and 
non-RA controls.  
Methods: Participants were patients on anti-TNF for more than two years (tRA) with DAS<3.2; 
patients on conventional DMARDs with DAS>3.2 (aRA) and healthy controls (C), matched for age and 
BMI. Physical activity was assessed using the Actigraph GT3x+ accelerometer, worn throughout 
waking hours for seven days to determine time spent in light activity, moderate to vigorous physical 
activity (MVPA) and sedentary time. The International Physical Activity Questionnaire (IPAQ) was 
also completed. Groups were compared using analysis of variance with Bonferroni post hoc tests; 
Kruskal-Wallis or Mann-Whitney U- test as appropriate. 
Results: RA disease duration was significantly greater in tRA than aRA. Groups did not differ 
significantly in age, height, weight or body mass index (Table). Daily step count was significantly 
lower in aRA than tRA and C. Sedentary time (as a proportion of wear time) was significantly greater 
in aRA than tRA, whilst the reverse was true for light activity time. MVPA time was significantly lower 
in both RA groups than in controls. IPAQ questionnaires demonstrated significant differences 
between groups, with substantially higher values in C than RA groups in total METs and MET-
minutes per week in domestic and garden, leisure, walking activities as well as total moderate and 
vigorous activities. RA patients had lower moderate to vigorous activity time than controls, 
regardless of treatment. aRA had lower light activity time, and more sedentary time, than tRA 
Conclusion: Moderate to vigorous physical activity should be promoted in all RA patients as even 
those with well controlled disease exhibit a deficit in comparison to controls 
 
 
 
 
  
Table: Characteristics of Anti-TNF (tRA), Active Rheumatoid Disease (aRA) and control (C) groups: 
Mean (SD) or Median (inter-quartile range) 
 
tRA (n=40) aRA (n=32) C (n=34) P  
Age (y) 59.0 + 10.4 60.4 + 10.6 60.8 + 10.5 0.748 
BMI (kgm-2) 25.7 + 4.5 27.7 + 5.6 25.1 + 3.2 0.072 
HAQ 0.7 + 0.6 a 1.2 + 0.6 a c 0.1 + 0.1 c <0.001 
DAS28 2.7 (0.9) a 5.3 (1.2) a 
 
<0.001 
RA disease duration (y) 15.8 + 9.2 a 9.6 + 9.6 a - 0.006 
 
 
 
 
